Circular RNA expression profiles and bioinformatic analysis in coronary heart disease

Fangpu Yu1, Yuanyuan Tie1, Ya Zhang1

  • 1The Key Laboratory of Cardiovascular Remodeling & Function Research, Chinese Ministry of Education, Chinese Ministry of Health & Chinese Academy of Medical Sciences, & The State & Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Qilu Hospital of Shandong University, Jinan 250012, Shandong, PR China.

Epigenomics
|February 12, 2020
PubMed

Insights

Circular RNAs (circRNAs) show altered expression in coronary heart disease (CHD). These dysregulated circRNAs may influence CHD by acting as competing endogenous RNAs (ceRNAs).

Area of Science:

  • Genomics
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Coronary heart disease (CHD) is a significant global health concern.
  • The role of circular RNAs (circRNAs) in CHD pathogenesis remains largely unexplored.

Purpose of the Study:

  • To investigate the expression profile of circRNAs in patients with CHD.
  • To elucidate the potential role of circRNAs in the pathophysiology of CHD.

Main Methods:

  • CircRNA expression profiling was performed using sequence analysis on peripheral blood mononuclear cells from 70 CHD patients and 30 controls.
  • Quantitative real-time polymerase chain reaction (qRT-PCR) was used to validate selected circRNAs in human atherosclerotic coronary arteries.

Main Results:

  • A total of 2283 downregulated and 85 upregulated circRNAs were identified in CHD patients.
  • Parental genes of the top 100 dysregulated circRNAs are associated with metabolism and protein modification.
  • Twelve circRNAs were predicted to upregulate their CHD-related parental genes via miRNA sponge mechanisms.
  • Six of eight validated circRNAs in atherosclerotic coronary arteries showed results consistent with peripheral blood mononuclear cell sequencing.

Conclusions:

  • Dysregulated circRNAs exhibit altered expression patterns in CHD.
  • circRNAs may function as competing endogenous RNAs (ceRNAs) in CHD.
  • These findings suggest a potential role for circRNAs in the development and progression of CHD.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
304
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
4.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
797